BWAY Stock Analysis: Buy, Sell, or Hold?
BWAY - Brainsway Ltd. American Depositary Shares
$12.75
-0.13 (-0.97%)
▼
5d:
-7.04%
30d:
-44.92%
90d:
-34.2%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When BWAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BWAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BWAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.75
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.50
5.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BWAY is currently trading at $12.74, which is considered slightly low relative to its 30-day fair value range of $11.73 to $21.62. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.8) compared to its historical average (75.0). Remarkably, the market is currently pricing in an annual earnings decline of 27.3% over the next few years. This pessimistic expectation contrasts with the company's recent 390.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BWAY is showing sideways momentum. The price is currently testing key support at $12.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BWAY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.33 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BWAY is showing sideways momentum. The price is currently testing key support at $12.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BWAY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.33 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$11.73 -
$21.62
Company Quality Score
47/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
84.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($15.33)
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$11.73 -
$21.62
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.31
(10.3%)
Support & Resistance Levels
Support Level
$12.41
Resistance Level
$14.10
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.81
Wall Street Target
$15.33
(+19.1%)
Revenue Growth (YoY)
27.4%
Earnings Growth (YoY)
390.8%
Profit Margin
14.6%
Valuation Discount vs History
-27.3% cheaper
PE vs Historical
28.8 vs 75.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-27.3%
(market-implied from PE analysis)
1-Year Target
$11.58
(-10%)
2-Year Target
$10.42
(-19%)
3-Year Target
$9.38
(-27%)
3-Yr Target (if PE normalizes)
(PE: 29→75)
$24.42
(+90%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.8, Growth: 45.6%)
$39.76
(+209%)
Base:
(SPY PE: 22.4, Growth: 45.6%)
$30.92
(+140%)
Bear:
(PE: 19.0, Growth: 45.6%)
$26.28
(+104%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (76x PE), but valuation improves significantly next year (29x PE) as earnings recover.
Trailing PE: 75.89 | Current EPS (TTM): $0.18
Bull Case
$30.05
(+119%)
Analyst growth 100.0%, PE expands to 83.5
Base Case
$27.32
(+99%)
Market implied 100.0%, PE stable at 75.9
Bear Case
$9.29
(-32%)
Severe decline -20.0%, PE contracts to 64.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.8 to 75.0
Stabilization Target:
$33.50
(+160.3%)
PE Expansion Potential:
+160.3%
Share & Embed Analysis
Last updated: March 30, 2026 2:53 PM ET
Data refreshes hourly during market hours. Next update: 3:53 PM
Data refreshes hourly during market hours. Next update: 3:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BWAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 59 HOLD |
